CARBIDOPA, LEVODOPA AND ENTACAPONE

CARBIDOPA, LEVODOPA AND ENTACAPONE was reported 481 times

CARBIDOPA, LEVODOPA AND ENTACAPONE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 ADRENAL MEDULLA HYPERFUNCTION 1 1.0000
1 STOMA SITE CANDIDA 2 0.0741
2 STOMA SITE DERMATITIS 2 0.0606
3 PYLORUS DILATATION 1 0.0500
4 HYPOINSULINAEMIA 1 0.0345
5 GASTROLITHIASIS 1 0.0333
6 MEDICAL DEVICE SITE DISCOLOURATION 1 0.0233
7 MEDICAL DEVICE SITE ULCER 1 0.0208
8 STOMA SITE EXTRAVASATION 8 0.0207
9 TRACHEAL CANCER 1 0.0179
10 STOMA SITE ABSCESS 3 0.0123
11 GASTROINTESTINAL ULCER PERFORATION 1 0.0108
12 SUPPORTIVE CARE 1 0.0099
13 STOMA SITE IRRITATION 5 0.0092
14 STOMA SITE DISCOMFORT 2 0.0088
15 SENILE OSTEOPOROSIS 1 0.0081
16 STOMA SITE HYPERGRANULATION 5 0.0079
17 MEDICAL DEVICE SITE PAIN 4 0.0071
18 DEEP BRAIN STIMULATION 4 0.0066
19 PELVIC PROLAPSE 1 0.0056
20 JEJUNOSTOMY 1 0.0055
21 STOMA SITE PAIN 8 0.0054
22 STOMA SITE ERYTHEMA 10 0.0053
23 ARTERIAL SPASM 1 0.0051
24 GASTROSTOMY TUBE SITE COMPLICATION 1 0.0050
25 INTENTIONAL MEDICAL DEVICE REMOVAL BY PATIENT 5 0.0050
26 DEVICE COLOUR ISSUE 2 0.0050
27 STOMA SITE OEDEMA 1 0.0046
28 MALABSORPTION FROM ADMINISTRATION SITE 1 0.0043
29 PENILE HAEMATOMA 1 0.0043
30 STOMA SITE DISCHARGE 11 0.0040
31 STOMA COMPLICATION 4 0.0039
32 CYTOTOXIC OEDEMA 1 0.0038
33 MEDICAL DEVICE CHANGE 2 0.0038
34 TONGUE SPASM 1 0.0032
35 DEVICE PROGRAMMING ERROR 1 0.0032
36 STOMA SITE INFECTION 4 0.0031
37 PNEUMOCEPHALUS 1 0.0030
38 REHABILITATION THERAPY 11 0.0028
39 RADIAL NERVE PALSY 1 0.0028
40 ON AND OFF PHENOMENON 15 0.0027
41 STOMA SITE INFLAMMATION 2 0.0027
42 OBSTRUCTIVE UROPATHY 1 0.0025
43 GIANT CELL ARTERITIS 2 0.0024
44 INCORRECT PRODUCT DOSAGE FORM ADMINISTERED 1 0.0024
45 BELLIGERENCE 1 0.0023
46 DEVICE LOOSENING 2 0.0023
47 HALLUCINATION, OLFACTORY 1 0.0023
48 OESOPHAGEAL DILATATION 1 0.0023
49 DOPAMINE DYSREGULATION SYNDROME 1 0.0022
50 CARDIAC PACEMAKER REPLACEMENT 1 0.0022
51 SEXUALLY INAPPROPRIATE BEHAVIOUR 1 0.0021
52 CEREBRAL HYPOPERFUSION 1 0.0021
53 LIVING IN RESIDENTIAL INSTITUTION 4 0.0021
54 INFUSION SITE HAEMATOMA 1 0.0021
55 VITREOUS DISORDER 1 0.0021
56 GASTRIC PH DECREASED 2 0.0020
57 PHYSIOTHERAPY 1 0.0019
58 THYROID CYST 1 0.0017
59 SINOATRIAL BLOCK 1 0.0017
60 DEVICE ALARM ISSUE 3 0.0017
61 FREEZING PHENOMENON 6 0.0016
62 BLOOD CORTISOL DECREASED 1 0.0016
63 POSTURE ABNORMAL 5 0.0015
64 PHAEOCHROMOCYTOMA 1 0.0015
65 CHRONIC MYELOMONOCYTIC LEUKAEMIA 1 0.0015
66 HEAT ILLNESS 1 0.0015
67 NASAL DISCHARGE DISCOLOURATION 2 0.0014
68 DISCHARGE 2 0.0014
69 DIET REFUSAL 1 0.0014
70 INFUSION SITE INDURATION 2 0.0013
71 INDIFFERENCE 1 0.0013
72 GASTROINTESTINAL SURGERY 1 0.0013
73 STOMA SITE HAEMORRHAGE 2 0.0013
74 NONSPECIFIC REACTION 7 0.0013
75 DEVICE DAMAGE 1 0.0013
76 ANTICHOLINERGIC SYNDROME 2 0.0013
77 PARATHYROID DISORDER 1 0.0012
78 INFUSION SITE DISCOLOURATION 1 0.0011
79 KYPHOSIS 2 0.0011
80 PLEUROTHOTONUS 1 0.0011
81 DEVICE KINK 4 0.0011
82 ADVERSE FOOD REACTION 1 0.0011
83 INFUSION SITE NODULE 1 0.0010
84 AUTONOMIC NEUROPATHY 1 0.0010
85 CONSCIOUSNESS FLUCTUATING 1 0.0010
86 TEETH BRITTLE 1 0.0010
87 DEVICE CONNECTION ISSUE 2 0.0009
88 HYPERKINESIA 2 0.0009
89 MEDICAL DEVICE PAIN 2 0.0009
90 INFUSION SITE MASS 1 0.0009
91 TOXIC ANTERIOR SEGMENT SYNDROME 1 0.0009
92 GASTROINTESTINAL ULCER HAEMORRHAGE 1 0.0009
93 DRUG EFFECT VARIABLE 1 0.0009
94 THYROTOXIC CRISIS 1 0.0009
95 DEVICE OCCLUSION 12 0.0009
96 SENSE OF OPPRESSION 1 0.0008
97 LABILE BLOOD PRESSURE 1 0.0008
98 DELUSION 13 0.0008
99 POSTOPERATIVE WOUND COMPLICATION 1 0.0008
100 CALCIUM DEFICIENCY 1 0.0008
101 PACKED RED BLOOD CELL TRANSFUSION 1 0.0008
102 INTESTINAL DILATATION 1 0.0007
103 SKIN DEPIGMENTATION 1 0.0007
104 CALCULUS BLADDER 1 0.0007
105 JOINT INSTABILITY 1 0.0007
106 PORPHYRIA ACUTE 1 0.0007
107 NOROVIRUS INFECTION 1 0.0007
108 HALLUCINATION 52 0.0007
109 JUDGEMENT IMPAIRED 1 0.0007
110 DEVICE POWER SOURCE ISSUE 2 0.0007
111 DYSKINESIA 27 0.0007
112 PALLIATIVE CARE 1 0.0007
113 GASTROSTOMY 1 0.0006
114 MEDICAL DEVICE IMPLANTATION 1 0.0006
115 TINEA PEDIS 1 0.0006
116 SKULL FRACTURE 1 0.0006
117 OXYGEN THERAPY 1 0.0006
118 SUDDEN CARDIAC DEATH 2 0.0006
119 LAZINESS 1 0.0006
120 PUPIL FIXED 1 0.0006
121 ROTATOR CUFF REPAIR 1 0.0006
122 EMOTIONAL POVERTY 1 0.0006
123 INFUSION SITE DISCHARGE 1 0.0006
124 BURNS SECOND DEGREE 1 0.0006
125 HALLUCINATION, VISUAL 12 0.0006
126 LOGORRHOEA 2 0.0006
127 SINUS NODE DYSFUNCTION 1 0.0005
128 HYPOMANIA 2 0.0005
129 DISORGANISED SPEECH 1 0.0005
130 TRAUMATIC HAEMORRHAGE 1 0.0005
131 FACE INJURY 2 0.0005
132 THERAPEUTIC PRODUCT EFFECT VARIABLE 2 0.0005
133 BRADYKINESIA 3 0.0005
134 HOSPICE CARE 5 0.0005
135 MUSCLE HAEMORRHAGE 2 0.0005
136 LIBIDO INCREASED 1 0.0005
137 DECUBITUS ULCER 4 0.0005
138 DERMATITIS PSORIASIFORM 1 0.0005
139 EXTRAVASATION 2 0.0005
140 HYPERPARATHYROIDISM 1 0.0005
141 SPINAL STENOSIS 2 0.0005
142 AKINESIA 1 0.0005
143 HALLUCINATIONS, MIXED 2 0.0005
144 SCREAMING 3 0.0005
145 OCULOGYRIC CRISIS 1 0.0005
146 ABSCESS INTESTINAL 1 0.0005
147 INFUSION SITE BRUISING 1 0.0005
148 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 4 0.0005
149 GASTROINTESTINAL ULCER 1 0.0005
150 SPINAL COLUMN INJURY 1 0.0004
151 TERMINAL STATE 3 0.0004
152 LARGE INTESTINAL OBSTRUCTION 1 0.0004
153 CORNEAL OEDEMA 1 0.0004
154 COMPUTERISED TOMOGRAM ABNORMAL 1 0.0004
155 LUMBAR VERTEBRAL FRACTURE 2 0.0004
156 RED BLOOD CELL SEDIMENTATION RATE ABNORMAL 1 0.0004
157 NECK SURGERY 1 0.0004
158 URINARY TRACT OBSTRUCTION 1 0.0004
159 GAIT INABILITY 14 0.0004
160 LACUNAR INFARCTION 1 0.0004
161 LIMB OPERATION 2 0.0004
162 WEIGHT ABNORMAL 1 0.0004
163 PRODUCT PACKAGING CONFUSION 1 0.0004
164 RETINAL TEAR 1 0.0004
165 GASTROINTESTINAL TUBE INSERTION 1 0.0004
166 URINARY TRACT INFECTION BACTERIAL 1 0.0004
167 ENDODONTIC PROCEDURE 1 0.0004
168 PARKINSON'S DISEASE 1 0.0004
169 DIABETIC COMPLICATION 1 0.0004
170 MOTOR DYSFUNCTION 4 0.0004
171 PHYSICAL DECONDITIONING 1 0.0004
172 HERNIA REPAIR 1 0.0004
173 PSYCHOMOTOR SKILLS IMPAIRED 1 0.0004
174 YAWNING 1 0.0004
175 BREAST SWELLING 1 0.0004
176 PRODUCT RESIDUE PRESENT 2 0.0004
177 BEHAVIOUR DISORDER 2 0.0004
178 SKIN LACERATION 4 0.0004
179 ASPIRATION 4 0.0004
180 ENDOTRACHEAL INTUBATION 1 0.0004
181 ORTHOSTATIC HYPOTENSION 6 0.0003
182 HIP FRACTURE 11 0.0003
183 ENERGY INCREASED 2 0.0003
184 INFUSION SITE REACTION 1 0.0003
185 CRANIOCEREBRAL INJURY 1 0.0003
186 EYE INJURY 1 0.0003
187 SPINAL OPERATION 4 0.0003
188 BLOOD BLISTER 1 0.0003
189 RESPIRATORY RATE DECREASED 1 0.0003
190 POLYMYALGIA RHEUMATICA 1 0.0003
191 UNRESPONSIVE TO STIMULI 8 0.0003
192 INCOHERENT 2 0.0003
193 BACTERIAL SEPSIS 1 0.0003
194 INFUSION SITE HAEMORRHAGE 1 0.0003
195 DYSGRAPHIA 2 0.0003
196 SUSPECTED COVID-19 1 0.0003
197 EXPIRED DEVICE USED 1 0.0003
198 SALIVARY HYPERSECRETION 3 0.0003
199 ANXIETY DISORDER 1 0.0003
200 CEREBRAL HAEMATOMA 1 0.0003
201 WOUND DEHISCENCE 1 0.0003
202 REGURGITATION 1 0.0003
203 CERVICAL VERTEBRAL FRACTURE 1 0.0003
204 DROOLING 2 0.0003
205 HYPOPNOEA 1 0.0003
206 HEAD INJURY 9 0.0003
207 FACIAL PARESIS 1 0.0003
208 HAND FRACTURE 2 0.0003
209 DEVICE PLACEMENT ISSUE 1 0.0003
210 DEVICE DISLOCATION 12 0.0003
211 WOUND INFECTION 3 0.0003
212 INTENTIONAL UNDERDOSE 2 0.0003
213 AMYLASE INCREASED 1 0.0003
214 GENERAL SYMPTOM 2 0.0003
215 GASTRIC INFECTION 1 0.0003
216 OESOPHAGEAL ULCER 1 0.0003
217 GASTROINTESTINAL INFLAMMATION 2 0.0003
218 MUSCLE RIGIDITY 3 0.0003
219 ATRIAL FLUTTER 2 0.0003
220 PRESCRIBED UNDERDOSE 5 0.0003
221 DEMENTIA 7 0.0003
222 VITAMIN B12 DEFICIENCY 1 0.0002
223 SHOCK HAEMORRHAGIC 2 0.0002
224 HYPERPYREXIA 1 0.0002
225 MUSCLE FATIGUE 1 0.0002
226 BUNDLE BRANCH BLOCK LEFT 1 0.0002
227 CARDIAC FAILURE CHRONIC 1 0.0002
228 DEVICE ISSUE 21 0.0002
229 ONYCHOMYCOSIS 1 0.0002
230 ABDOMINAL ABSCESS 1 0.0002
231 CATHETERISATION CARDIAC 1 0.0002
232 WHEELCHAIR USER 1 0.0002
233 ANAL INCONTINENCE 2 0.0002
234 URINARY TRACT DISORDER 1 0.0002
235 OROPHARYNGEAL DISCOMFORT 2 0.0002
236 EYE OPERATION 1 0.0002
237 IRON DEFICIENCY ANAEMIA 2 0.0002
238 ARTHRITIS INFECTIVE 1 0.0002
239 SEASONAL ALLERGY 3 0.0002
240 VULVOVAGINAL PAIN 1 0.0002
241 FALL 69 0.0002
242 DYSTONIA 4 0.0002
243 HAEMORRHOIDAL HAEMORRHAGE 1 0.0002
244 INCORRECT DOSAGE ADMINISTERED 1 0.0002
245 HYPERVOLAEMIA 1 0.0002
246 FOOT OPERATION 1 0.0002
247 GASTROINTESTINAL SOUNDS ABNORMAL 1 0.0002
248 INFLAMMATORY MARKER INCREASED 1 0.0002
249 UPPER LIMB FRACTURE 4 0.0002
250 PNEUMONIA ASPIRATION 5 0.0002
251 FLUID INTAKE REDUCED 1 0.0002
252 FEEDING DISORDER 4 0.0002
253 HIP ARTHROPLASTY 3 0.0002
254 FEMORAL NECK FRACTURE 1 0.0002
255 MOBILITY DECREASED 14 0.0002
256 RIB FRACTURE 4 0.0002
257 FAILURE TO THRIVE 1 0.0002
258 BRAIN FOG 3 0.0002
259 INCONTINENCE 2 0.0002
260 GASTROINTESTINAL MOTILITY DISORDER 1 0.0002
261 HIP SURGERY 1 0.0002
262 PULMONARY THROMBOSIS 2 0.0002
263 INTERVERTEBRAL DISC PROTRUSION 4 0.0002
264 FAECALOMA 1 0.0002
265 PSYCHOMOTOR HYPERACTIVITY 3 0.0002
266 GASTRIC ULCER HAEMORRHAGE 1 0.0002
267 FOOT DEFORMITY 2 0.0002
268 MACULAR OEDEMA 1 0.0002
269 ABNORMAL BEHAVIOUR 7 0.0002
270 NEUTROPHILIA 1 0.0002
271 MICTURITION URGENCY 2 0.0002
272 PARANOIA 3 0.0002
273 GASTRIC HAEMORRHAGE 2 0.0002
274 CATARACT OPERATION 1 0.0002
275 MACULAR DEGENERATION 2 0.0002
276 BLOOD PRESSURE INADEQUATELY CONTROLLED 1 0.0002
277 AGGRESSION 8 0.0002
278 URINARY TRACT INFECTION 27 0.0002
279 C-REACTIVE PROTEIN ABNORMAL 1 0.0002
280 INFUSION SITE PAIN 2 0.0002
281 NODULE 2 0.0002
282 REFUSAL OF TREATMENT BY PATIENT 1 0.0002
283 SPEECH DISORDER 8 0.0002
284 SARS-COV-2 TEST POSITIVE 2 0.0002
285 BLOOD PRESSURE ABNORMAL 3 0.0002
286 THERAPEUTIC RESPONSE SHORTENED 5 0.0002
287 COGNITIVE DISORDER 7 0.0001
288 JOINT RANGE OF MOTION DECREASED 2 0.0001
289 CONFUSIONAL STATE 24 0.0001
290 JOINT EFFUSION 1 0.0001
291 COORDINATION ABNORMAL 2 0.0001
292 DUODENAL ULCER 1 0.0001
293 DIVERTICULUM 1 0.0001
294 SUBDURAL HAEMATOMA 2 0.0001
295 HYPERSOMNIA 4 0.0001
296 BALANCE DISORDER 12 0.0001
297 DEVICE LEAKAGE 6 0.0001
298 FAECES SOFT 1 0.0001
299 DYSSTASIA 4 0.0001
300 BLOOD PRESSURE DIASTOLIC DECREASED 1 0.0001
301 PSYCHOTIC DISORDER 4 0.0001
302 HYPOPHOSPHATAEMIA 1 0.0001
303 HAEMORRHAGE INTRACRANIAL 2 0.0001
304 KETOACIDOSIS 1 0.0001
305 BLOOD POTASSIUM DECREASED 4 0.0001
306 APHASIA 4 0.0001
307 DISSOCIATION 1 0.0001
308 CONCUSSION 1 0.0001
309 APNOEA 1 0.0001
310 ELECTROCARDIOGRAM ABNORMAL 1 0.0001
311 DISORIENTATION 5 0.0001
312 MUSCULOSKELETAL STIFFNESS 11 0.0001
313 STENT PLACEMENT 1 0.0001
314 MUSCLE DISORDER 1 0.0001
315 AGITATION 9 0.0001
316 ASPHYXIA 1 0.0001
317 ADVERSE DRUG REACTION 11 0.0001
318 MANIA 2 0.0001
319 UPPER-AIRWAY COUGH SYNDROME 1 0.0001
320 UPPER GASTROINTESTINAL HAEMORRHAGE 2 0.0001
321 ABDOMINAL PAIN LOWER 3 0.0001
322 INFUSION SITE ERYTHEMA 1 0.0001
323 TRANSIENT ISCHAEMIC ATTACK 4 0.0001
324 NIGHTMARE 4 0.0001
325 DIPLOPIA 3 0.0001
326 DELIRIUM 4 0.0001
327 DEVICE USE ISSUE 2 0.0001
328 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 8 0.0001
329 GASTROENTERITIS VIRAL 2 0.0001
330 RESTLESS LEGS SYNDROME 2 0.0001
331 PNEUMONIA BACTERIAL 1 0.0001
332 BLOOD THYROID STIMULATING HORMONE INCREASED 1 0.0001
333 UROSEPSIS 1 0.0001
334 PRODUCT DISTRIBUTION ISSUE 1 0.0001
335 THINKING ABNORMAL 2 0.0001
336 LACERATION 1 0.0001
337 BLOOD SODIUM DECREASED 2 0.0001
338 MUSCULAR WEAKNESS 12 0.0001
339 FOOT FRACTURE 2 0.0001
340 SPUTUM DISCOLOURED 1 0.0001
341 PRODUCT PACKAGING ISSUE 1 0.0001
342 COMA 5 0.0001
343 PARKINSONISM 1 0.0001
344 BLOOD PRESSURE SYSTOLIC INCREASED 2 0.0001
345 VITAMIN D DEFICIENCY 1 0.0001
346 CHOKING 2 0.0001
347 URINARY INCONTINENCE 3 0.0001
348 LIGAMENT SPRAIN 1 0.0001
349 BLADDER DISORDER 1 0.0001
350 HYPOTONIA 1 0.0001
351 PRODUCT ADMINISTRATION ERROR 2 0.0001
352 HYPOTHERMIA 1 0.0001
353 DEVICE BREAKAGE 4 0.0001
354 DRY THROAT 1 0.0001
355 SLUGGISHNESS 1 0.0001
356 INITIAL INSOMNIA 1 0.0001
357 LIMB DISCOMFORT 3 0.0001
358 FEMUR FRACTURE 3 0.0001
359 TRANSFUSION 1 0.0001
360 SCRATCH 1 0.0001
361 JOINT DISLOCATION 1 0.0001
362 BODY HEIGHT DECREASED 1 0.0001
363 MOVEMENT DISORDER 3 0.0001
364 HEREDITARY ANGIOEDEMA 1 0.0001
365 POOR QUALITY SLEEP 2 0.0001
366 BIPOLAR DISORDER 1 0.0001
367 CLOSTRIDIUM DIFFICILE INFECTION 2 0.0001
368 DENTAL CARIES 1 0.0001
369 RED BLOOD CELL SEDIMENTATION RATE INCREASED 1 0.0001
370 DEHYDRATION 12 0.0001
371 NERVE INJURY 1 0.0001
372 HYPERTENSIVE CRISIS 1 0.0001
373 SOMNOLENCE 18 0.0001
374 SKIN INFECTION 1 0.0001
375 INTESTINAL PERFORATION 1 0.0001
376 GAIT DISTURBANCE 17 0.0001
377 CHROMATURIA 2 0.0001
378 DERMATITIS CONTACT 1 0.0001
379 SCAB 1 0.0001
380 MUSCLE TWITCHING 2 0.0001
381 UNINTENTIONAL MEDICAL DEVICE REMOVAL 1 0.0001
382 POST PROCEDURAL HAEMORRHAGE 1 0.0001
383 PRODUCT DOSE OMISSION ISSUE 25 0.0001
384 NEUROLEPTIC MALIGNANT SYNDROME 1 0.0001
385 DYSPHAGIA 8 0.0001
386 ACCIDENT 1 0.0001
387 HYPERLIPIDAEMIA 1 0.0001
388 BLOOD PRESSURE FLUCTUATION 2 0.0001
389 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 4 0.0001
390 LOCALISED INFECTION 2 0.0001
391 CARDIOMEGALY 1 0.0001
392 TENDON RUPTURE 1 0.0001
393 ILEUS 1 0.0001
394 TOOTH EXTRACTION 1 0.0001
395 SECRETION DISCHARGE 1 0.0001
396 DYSARTHRIA 3 0.0001
397 COLITIS 3 0.0001
398 MUSCLE ATROPHY 1 0.0001
399 TREMOR 13 0.0001
400 HYPOPHAGIA 2 0.0001
401 HOSPITALISATION 12 0.0001
402 HIATUS HERNIA 1 0.0001
403 HAEMATOMA 2 0.0001
404 BEDRIDDEN 1 0.0001
405 TOOTH INFECTION 1 0.0001
406 PULMONARY CONGESTION 1 0.0001
407 FEAR 2 0.0001
408 CONSTIPATION 16 0.0001
409 IMPAIRED GASTRIC EMPTYING 1 0.0001
410 MOOD ALTERED 2 0.0001
411 AKATHISIA 1 0.0001
412 DEVICE DELIVERY SYSTEM ISSUE 2 0.0001
413 DIVERTICULITIS 2 0.0001
414 LETHARGY 4 0.0001
415 ANOSMIA 1 0.0001
416 MENTAL DISORDER 3 0.0001
417 COMPLICATION ASSOCIATED WITH DEVICE 1 0.0001
418 APATHY 1 0.0001
419 UNDERDOSE 5 0.0001
420 DRUG EFFECT LESS THAN EXPECTED 1 0.0001
421 THERAPEUTIC PRODUCT EFFECT DECREASED 3 0.0001
422 THERAPY NON-RESPONDER 3 0.0001
423 HYPOAESTHESIA ORAL 1 0.0001
424 INSURANCE ISSUE 1 0.0001
425 LYMPHOMA 1 0.0001
426 MUSCULOSKELETAL CHEST PAIN 1 0.0001
427 ANKLE FRACTURE 1 0.0001
428 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 3 0.0001
429 CARDIAC DISORDER 6 0.0001
430 THERAPY PARTIAL RESPONDER 1 0.0001
431 INSOMNIA 17 0.0001
432 CYANOSIS 1 0.0001
433 PRODUCT USE COMPLAINT 1 0.0001
434 HALLUCINATION, AUDITORY 1 0.0001
435 ULCER 1 0.0001
436 CYSTITIS 2 0.0001
437 SCIATICA 1 0.0001
438 DEATH 54 0.0001
439 BLOOD POTASSIUM INCREASED 1 0.0001
440 PRODUCT DOSE OMISSION 4 0.0001
441 SEIZURE 7 0.0001
442 CARDIAC ARREST 5 0.0001
443 GENERALISED TONIC-CLONIC SEIZURE 1 0.0001
444 BLOOD PRESSURE DECREASED 4 0.0001
445 SYNCOPE 6 0.0001
446 URINARY RETENTION 2 0.0001
447 HYPOTENSION 12 0.0001
448 CELLULITIS 3 0.0001
449 HAEMOGLOBIN DECREASED 6 0.0001
450 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 1 0.0001
451 MEMORY IMPAIRMENT 8 0.0001
452 DEVICE DEFECTIVE 1 0.0001
453 NERVOUSNESS 3 0.0001
454 THIRST 1 0.0001
455 CEREBRAL HAEMORRHAGE 2 0.0001
456 PANIC ATTACK 2 0.0001
457 TREATMENT NONCOMPLIANCE 3 0.0001
458 RESTLESSNESS 2 0.0001
459 INFLUENZA 6 0.0001
460 NECK PAIN 3 0.0001
461 BACTERIAL INFECTION 1 0.0001
462 MIDDLE INSOMNIA 1 0.0001
463 DYSPNOEA EXERTIONAL 2 0.0001
464 INTESTINAL OBSTRUCTION 2 0.0001
465 UNEVALUABLE EVENT 4 0.0001
466 HYPOCALCAEMIA 1 0.0001
467 FRACTURE 1 0.0001
468 GASTRIC ULCER 1 0.0001
469 MUSCULOSKELETAL DISORDER 1 0.0001
470 SEROTONIN SYNDROME 1 0.0001
471 LOWER LIMB FRACTURE 1 0.0001
472 PERIPHERAL SWELLING 8 0.0001
473 ERUCTATION 1 0.0001
474 EAR PAIN 1 0.0001
475 HAEMORRHOIDS 1 0.0001
476 SURGERY 3 0.0001
477 KIDNEY INFECTION 1 0.0001
478 DEPRESSED LEVEL OF CONSCIOUSNESS 2 0.0001
479 WEIGHT DECREASED 14 0.0001
480 SPINAL FRACTURE 1 0.0000
481 CONDITION AGGRAVATED 15 0.0000
482 TASTE DISORDER 1 0.0000
483 VERTIGO 3 0.0000
484 INJURY ASSOCIATED WITH DEVICE 1 0.0000
485 BODY TEMPERATURE INCREASED 1 0.0000
486 POLLAKIURIA 2 0.0000
487 ABDOMINAL DISTENSION 5 0.0000
488 KNEE ARTHROPLASTY 1 0.0000
489 MOUTH ULCERATION 1 0.0000
490 CEREBROVASCULAR ACCIDENT 8 0.0000
491 LOSS OF CONSCIOUSNESS 6 0.0000
492 JOINT INJURY 1 0.0000
493 INTENTIONAL OVERDOSE 3 0.0000
494 PNEUMONIA 15 0.0000
495 PRODUCT DISPENSING ERROR 1 0.0000
496 DEVICE DIFFICULT TO USE 3 0.0000
497 ASTHENIA 17 0.0000
498 HEART RATE IRREGULAR 1 0.0000
499 APPLICATION SITE PRURITUS 1 0.0000
500 MUSCLE SPASMS 8 0.0000
501 TINNITUS 2 0.0000
502 PERICARDIAL EFFUSION 1 0.0000
503 ABDOMINAL PAIN 10 0.0000
504 SLEEP DISORDER 3 0.0000
505 FEELING ABNORMAL 10 0.0000
506 PRESYNCOPE 1 0.0000
507 INJECTION SITE URTICARIA 1 0.0000
508 BLOOD ALKALINE PHOSPHATASE INCREASED 1 0.0000
509 EPISTAXIS 3 0.0000
510 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 7 0.0000
511 BACK PAIN 9 0.0000
512 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 2 0.0000
513 SEDATION 1 0.0000
514 DEPRESSED MOOD 2 0.0000
515 EAR INFECTION 1 0.0000
516 THROMBOSIS 3 0.0000
517 GASTROOESOPHAGEAL REFLUX DISEASE 3 0.0000
518 JAUNDICE 1 0.0000
519 DISTURBANCE IN ATTENTION 2 0.0000
520 LIMB INJURY 1 0.0000
521 HAEMATOCHEZIA 2 0.0000
522 MENTAL STATUS CHANGES 1 0.0000
523 FEELING COLD 1 0.0000
524 WOUND 1 0.0000
525 PRODUCT DOSE OMISSION IN ERROR 1 0.0000
526 MULTIPLE ORGAN DYSFUNCTION SYNDROME 1 0.0000
527 ANXIETY 10 0.0000
528 INTERNATIONAL NORMALISED RATIO INCREASED 1 0.0000
529 PRODUCT SUBSTITUTION ISSUE 2 0.0000
530 BLOOD CREATINE PHOSPHOKINASE INCREASED 1 0.0000
531 GENERAL PHYSICAL HEALTH DETERIORATION 4 0.0000
532 MALAISE 15 0.0000
533 COVID-19 6 0.0000
534 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 1 0.0000
535 LABORATORY TEST ABNORMAL 1 0.0000
536 GASTROINTESTINAL DISORDER 3 0.0000
537 RESPIRATORY DISORDER 1 0.0000
538 IRRITABILITY 2 0.0000
539 ILL-DEFINED DISORDER 2 0.0000
540 DISCOMFORT 2 0.0000
541 DRUG INEFFECTIVE 43 0.0000
542 EMOTIONAL DISORDER 1 0.0000
543 DIZZINESS 16 0.0000
544 SWELLING 3 0.0000
545 MIGRAINE 3 0.0000
546 MOOD SWINGS 1 0.0000
547 CONTUSION 3 0.0000
548 LACTIC ACIDOSIS 1 0.0000
549 ATRIAL FIBRILLATION 3 0.0000
550 CHOLELITHIASIS 1 0.0000
551 IMPAIRED HEALING 1 0.0000
552 STAPHYLOCOCCAL INFECTION 1 0.0000
553 HEART RATE INCREASED 3 0.0000
554 DECREASED APPETITE 7 0.0000
555 EXPIRED PRODUCT ADMINISTERED 1 0.0000
556 SKIN DISORDER 1 0.0000
557 TYPE 2 DIABETES MELLITUS 1 0.0000
558 ANGER 1 0.0000
559 HAEMATURIA 1 0.0000
560 ILLNESS 3 0.0000
561 DEVICE USE ERROR 1 0.0000
562 COUGH 8 0.0000
563 PRODUCT USE IN UNAPPROVED INDICATION 7 0.0000
564 PRODUCT ADHESION ISSUE 1 0.0000
565 THERAPY INTERRUPTED 2 0.0000
566 DRUG EFFECT INCOMPLETE 1 0.0000
567 DYSURIA 1 0.0000
568 HYPOAESTHESIA 4 0.0000
569 BLOOD PRESSURE INCREASED 4 0.0000
570 PLASMA CELL MYELOMA 1 0.0000
571 ARTHRITIS 2 0.0000
572 DRUG INTERACTION 4 0.0000
573 CARDIAC FAILURE 2 0.0000
574 EXTRA DOSE ADMINISTERED 1 0.0000
575 DRY MOUTH 2 0.0000
576 OSTEOPOROSIS 1 0.0000
577 VISUAL IMPAIRMENT 3 0.0000
578 DRUG DOSE OMISSION 4 0.0000
579 RHABDOMYOLYSIS 1 0.0000
580 GASTROINTESTINAL HAEMORRHAGE 2 0.0000
581 CARDIO-RESPIRATORY ARREST 1 0.0000
582 PAIN IN EXTREMITY 7 0.0000
583 HYPERHIDROSIS 3 0.0000
584 FATIGUE 18 0.0000
585 RASH 10 0.0000
586 MYOCARDIAL INFARCTION 4 0.0000
587 INTENTIONAL PRODUCT MISUSE 2 0.0000
588 TACHYCARDIA 2 0.0000
589 PULMONARY OEDEMA 1 0.0000
590 THERAPEUTIC RESPONSE UNEXPECTED 1 0.0000
591 THROAT IRRITATION 1 0.0000
592 VISION BLURRED 3 0.0000
593 SKIN IRRITATION 1 0.0000
594 ADVERSE EVENT 2 0.0000
595 OROPHARYNGEAL PAIN 2 0.0000
596 CHEST PAIN 4 0.0000
597 RENAL DISORDER 1 0.0000
598 ARRHYTHMIA 1 0.0000
599 PRODUCTIVE COUGH 1 0.0000
600 INFECTION 3 0.0000
601 DRY EYE 1 0.0000
602 SINUSITIS 2 0.0000
603 THERAPY CESSATION 1 0.0000
604 INFLAMMATION 1 0.0000
605 ARTHRALGIA 8 0.0000
606 HEADACHE 12 0.0000
607 HAEMORRHAGE 2 0.0000
608 PANCREATITIS 1 0.0000
609 BRADYCARDIA 1 0.0000
610 DRUG EFFECT DECREASED 1 0.0000
611 RASH PRURITIC 1 0.0000
612 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 1 0.0000
613 SEPSIS 2 0.0000
614 URTICARIA 3 0.0000
615 OXYGEN SATURATION DECREASED 1 0.0000
616 EYE PAIN 1 0.0000
617 NAUSEA 14 0.0000
618 DYSPNOEA 10 0.0000
619 FLATULENCE 1 0.0000
620 HERPES ZOSTER 1 0.0000
621 PYREXIA 6 0.0000
622 DYSPHONIA 1 0.0000
623 PALPITATIONS 2 0.0000
624 DISEASE PROGRESSION 2 0.0000
625 CATARACT 1 0.0000
626 SUICIDE ATTEMPT 1 0.0000
627 PLEURAL EFFUSION 1 0.0000
628 OEDEMA PERIPHERAL 2 0.0000
629 RHINORRHOEA 1 0.0000
630 DEEP VEIN THROMBOSIS 1 0.0000
631 AMNESIA 1 0.0000
632 INFUSION RELATED REACTION 1 0.0000
633 NEOPLASM MALIGNANT 1 0.0000
634 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 3 0.0000
635 HEPATIC ENZYME INCREASED 1 0.0000
636 PAIN 9 0.0000
637 INJURY 1 0.0000
638 HYPERTENSION 3 0.0000
639 OVERDOSE 3 0.0000
640 RESPIRATORY FAILURE 1 0.0000
641 DYSGEUSIA 1 0.0000
642 HOT FLUSH 1 0.0000
643 DEPRESSION 3 0.0000
644 CHRONIC KIDNEY DISEASE 1 0.0000
645 DIABETES MELLITUS 1 0.0000
646 VOMITING 6 0.0000
647 INJECTION SITE HAEMORRHAGE 1 0.0000
648 CARDIAC FAILURE CONGESTIVE 1 0.0000
649 INFLUENZA LIKE ILLNESS 1 0.0000
650 DRUG ABUSE 1 0.0000
651 INTENTIONAL PRODUCT USE ISSUE 1 0.0000
652 NASOPHARYNGITIS 2 0.0000
653 HYPERSENSITIVITY 2 0.0000
654 BLOOD GLUCOSE INCREASED 2 0.0000
655 NEUROPATHY PERIPHERAL 1 0.0000
656 ANAEMIA 2 0.0000
657 DYSPEPSIA 1 0.0000
658 FLUSHING 1 0.0000
659 CHEST DISCOMFORT 1 0.0000
660 MALIGNANT NEOPLASM PROGRESSION 1 0.0000
661 ERYTHEMA 2 0.0000
662 ABDOMINAL PAIN UPPER 2 0.0000
663 THROMBOCYTOPENIA 1 0.0000
664 RHEUMATOID ARTHRITIS 1 0.0000
665 INCORRECT DOSE ADMINISTERED 2 0.0000
666 CHILLS 1 0.0000
667 JOINT SWELLING 1 0.0000
668 PSORIASIS 1 0.0000
669 PRODUCT QUALITY ISSUE 1 0.0000
670 NEUTROPENIA 1 0.0000
671 ACUTE KIDNEY INJURY 1 0.0000
672 DIARRHOEA 4 0.0000
673 ABDOMINAL DISCOMFORT 1 0.0000
674 TOXICITY TO VARIOUS AGENTS 1 0.0000
675 OFF LABEL USE 5 0.0000
676 PRODUCT USE ISSUE 1 0.0000
677 INJECTION SITE PAIN 1 0.0000
678 PRURITUS 1 0.0000